Ribonucleic Acid (RNA) Cleanup Market Global Report 2026

The ribonucleic acid (RNA) cleanup market size has grown rapidly in recent years. It will grow from $1.6 billion in 2025 to $1.76 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to the increasing demand for molecular biology research, the rising adoption of RNA sequencing technologies, the growing need for high-quality nucleic acid samples, the expanding infectious disease testing applications, and the increasing biotechnology and pharmaceutical research activities.

The ribonucleic acid (RNA) cleanup market size is expected to see strong growth in the next few years. It will grow to $2.56 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to increasing demand for precision medicine applications, rising adoption of automated laboratory workflows, growing research activities in transcriptomics and genomic analysis, expanding clinical diagnostic applications, and increasing investments in life science research infrastructure. Major trends in the forecast period include growing adoption of high-purity RNA cleanup workflows for advanced molecular analysis, increasing development of automated RNA purification systems for improved laboratory efficiency, rising demand for contamination-free RNA sample preparation methods, expanding use of RNA cleanup processes in sequencing and gene expression studies, and increasing availability of specialized RNA cleanup kits for diverse sample types.

The increasing adoption of precision medicine is expected to propel the growth of the ribonucleic acid (RNA) cleanup market in the forecast period. Precision medicine refers to a healthcare approach that customizes treatment strategies based on individual patient characteristics, including genetic profiles, biomarkers, and disease phenotypes. The adoption of precision medicine is expanding due to advancements in biomarker discovery and molecular diagnostics, which enable more accurate identification and classification of respiratory and other complex conditions, supporting the selection of targeted therapies. Ribonucleic acid (RNA) cleanup supports precision medicine by ensuring the availability of high-quality, contaminant-free RNA for accurate gene expression analysis and molecular research, enabling clinicians and researchers to identify patient-specific biomarkers, develop targeted treatment approaches, and make more precise diagnostic and therapeutic decisions based on genetic information. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the Food and Drug Administration (FDA) authorized 16 new personalized therapies for patients with rare diseases in 2023, representing a significant increase compared with the six approvals recorded in 2022. Therefore, the increasing adoption of precision medicine is driving the growth of the ribonucleic acid (RNA) cleanup market.

Companies operating in the ribonucleic acid (RNA) cleanup market are focusing on developing innovative solutions, such as advanced RNA cleanup technologies, to address the rising demand for high-purity RNA isolation, next-generation sequencing preparation, and precision molecular research applications. These technologies utilize magnetic bead-based purification, automated cleanup workflows, and high-sensitivity nucleic acid processing methods to enhance RNA recovery efficiency and contaminant removal compared with traditional column-based purification techniques. In March 2024, New England Biolabs, a US-based biotechnology company, launched the Monarch Mag Viral DNA/RNA Extraction Kit, an innovative RNA cleanup and purification solution associated with this market. The platform utilizes magnetic bead-based technology to enable rapid and efficient RNA cleanup, inhibitor removal, and high-quality nucleic acid extraction for molecular diagnostics and sequencing workflows. It also provides automation compatibility, scalable sample processing, and enhanced RNA purity for advanced genomics and life sciences research applications.

In April 2023, MolGen B.V., a Netherlands-based biotechnology and life sciences technology company, acquired Synchron Instrumenten B.V. for an undisclosed amount. Through this acquisition, MolGen aimed to strengthen and broaden its laboratory automation capabilities by integrating Synchron’s custom liquid handling systems and robotic automation technologies with its DNA/RNA extraction and reagent portfolio, thereby enhancing its ability to provide end-to-end high-throughput workflows for genomics and molecular diagnostics applications. Synchron Instrumenten B.V. is a Netherlands-based laboratory automation company that specializes in providing systems designed to support RNA cleanup.

Major companies operating in the ribonucleic acid (rna) cleanup market are Agilent Technologies Inc., Bio-Rad Laboratories Inc., Creative Diagnostics Inc., Danaher Corporation, Enzo Biochem Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Geneaid Biotech Ltd., Macherey-Nagel GmbH & Co. KG, Merck KGaA, Miltenyi Biotec B.V., New England Biolabs Inc., Norgen Biotek Corp., Omega Bio-tek Inc., Promega Corporation, QIAGEN N.V., RayBiotech Inc., Revvity Inc., Takara Bio Inc., Thermo Fisher Scientific Inc., Zymo Research Corporation.

North America was the dominating region in the ribonucleic acid (RNA) cleanup market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) cleanup market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ribonucleic acid (RNA) cleanup market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.